MX9709390A - Cistatina e humana. - Google Patents
Cistatina e humana.Info
- Publication number
- MX9709390A MX9709390A MX9709390A MX9709390A MX9709390A MX 9709390 A MX9709390 A MX 9709390A MX 9709390 A MX9709390 A MX 9709390A MX 9709390 A MX9709390 A MX 9709390A MX 9709390 A MX9709390 A MX 9709390A
- Authority
- MX
- Mexico
- Prior art keywords
- polypeptide
- disclosed
- methods
- human
- human cystatin
- Prior art date
Links
- 101000884770 Homo sapiens Cystatin-M Proteins 0.000 title 1
- 102000051607 human CST6 Human genes 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 5
- 238000000034 method Methods 0.000 abstract 2
- 108091026890 Coding region Proteins 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 206010027476 Metastases Diseases 0.000 abstract 1
- 206010028289 Muscle atrophy Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 206010040070 Septic Shock Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 230000004075 alteration Effects 0.000 abstract 1
- 208000002925 dental caries Diseases 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 201000000585 muscular atrophy Diseases 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 238000010188 recombinant method Methods 0.000 abstract 1
- 230000002207 retinal effect Effects 0.000 abstract 1
- 230000036303 septic shock Effects 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Se describe un polipéptido CysE humano y el ADN (ARN) que codifica para tal polipéptido. También se proporciona un procedimiento para producir tal polipéptido por técnicas recombinantes. También se describen los métodos para utilizar polipéptido para tratar la osteoporosis, metástasis tumoral, infecciones microbianas, infecciones virales, choque séptico, inflamacion, irritacion genital, caries, caquexia y debilitameiento muscular. También se describen los métodos de diagnostico para detectar mutaciones en la secuencia codificadora y alteraciones en la concentracion de los polipéptidos en una muestra derivada de un huésped.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MXPA/A/1997/009390A MXPA97009390A (es) | 1997-12-02 | Cistatina e humana |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MXPA/A/1997/009390A MXPA97009390A (es) | 1997-12-02 | Cistatina e humana |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9709390A true MX9709390A (es) | 1998-07-31 |
| MXPA97009390A MXPA97009390A (es) | 1998-11-09 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA91134B (en) | New proteins produced by human lymphocytes,dna sequence encoding these proteins and their pharmaceutical and biological uses | |
| EP2258383A3 (en) | Antigenic peptides derived from telomerase | |
| NZ223506A (en) | Tissue factor protein, dna encoding it, vectors, host cells, production of the protein and pharmaceutical compositions | |
| BR0009505A (pt) | Compostos e processos para terapia e diagnóstico de câncer de pulmão | |
| AU1724795A (en) | Human tissue inhibitor of metalloproteinase-4 | |
| GEP20033002B (en) | Osteoprotegerin Binding Protein and Receptors | |
| DE69632536D1 (de) | Impfstoffe für das respiratorische-synzytial-virus mit nuklein säuren | |
| EP0837131A3 (en) | Staphylococcus fibronectin binding protein compounds | |
| WO1997032018A3 (en) | Hepatitis c virus ribozymes | |
| NO20004631D0 (no) | Forbindelser og fremgangsmÕter for terapi og diagnose av lungekreft | |
| DK0750672T3 (da) | DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse | |
| AU3406595A (en) | Nucleotide and amino acid sequences of the envelope 1 and core genes of hepatitis c virus | |
| EA199700256A1 (ru) | Выделенные последовательности днк, кодирующие капсидные белки l1 и l2 папилломавируса человека типа 18, вектор для экспресси последовательностей днк, способ получения вирусоподобных частиц и способ индуцирования иммунного ответа | |
| EP0826774A3 (en) | Staphylococcal Fab I enoyl-ACP reductase | |
| ATE297464T1 (de) | Pharmazeutische zusammensetzungen zur therapie der herzinsuffizienz | |
| NZ332369A (en) | Isolated nucleic acid molecules which code for GAGE tumor rejection antigen, the tumor rejection antigen, and uses thereof | |
| NZ335633A (en) | Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases | |
| EP0834568A3 (en) | Novel saliva binding protein | |
| EP0845535A3 (en) | Leader peptidase (lep) from Streptococcus | |
| MX9709390A (es) | Cistatina e humana. | |
| DE69924877D1 (en) | Humanes akt-3 protein | |
| WO1997035976A3 (en) | Epidermal differentiation factor | |
| IE890087L (en) | Recombinant human interleukin-1 alpha polypeptides | |
| AU2002336926A1 (en) | Composition comprising a parvovirus vp1-variant and a parvovirus ns1 protein for induction of cytolysis | |
| EP0990000A4 (en) | CONJUNCTIVE TISSUE GROWTH FACTOR 3 |